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Key points
• Cohort studies are by no means perfect but 
provide insight into how exposures at one 
time may be causal in later morbidity. 
• In asthma, cohort studies have identified 
many risk factors present in early life which 
modestly increase later risk for asthma.
• Cohort studies have identified factors 
which may be used to predict the risk for 
persistent of wheeze in young children. 
• Intervention studies demonstrate that 
single interventions are less likely to be 
effective when compared to studies which 
include more than one intervention.
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Childhood respiratory cohort
studies: do they generate useful
outcomes?
Educational aims
[ To describe the strengths and limitations of cohort studies.
[ To give insight into the likely magnitude of effect of exposures on asthma causation.
[ To summarise the relative weight of predictors of asthma prognosis.
[ To describe results from cohort studies where interventions were made.
Summary
Cohort studies give insight into the evolution of respiratory disease over time and
provide a low level of evidence for causation. The initial pioneering cohort studies
in which symptoms and/or exposures were captured in early life and related to
respiratory outcome in later life are now part of a large family which is diverse in
age and exposures; however, asthma remains a fairly constant outcome.
This article aims to first describe the strengths and weaknesses of the various
asthma cohort studies. Thereafter, the article aims to describe the insight that
cohort studies have given into asthma causation, with a focus on relative
magnitude of effect, and also to describe the relative weight of factors identified
in cohort studies as predictors of persisting asthma symptoms. It is clear
that many factors are implicated in asthma causation; in isolation, each exerts a
rather modest positive of negative effect on causation, but are likely to be acting
in combination and modifying each other’s relative risk. There is no single
‘‘good’’ predictor of asthma outcome, but the coexistence of parental asthma/
atopy in a child with at least three episodes of wheeze by their third birthday
indicates a high relative risk for asthma at 11–13 years of age. There remains no
cure for asthma and the next step needs to apply what cohort studies have taught
us to intervention studies where several exposures are modified in at risk
individuals during the first year of life.
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Introduction
For the purpose of this review, a cohort study is
defined as an observational study for which
measurements made at one point in time
are related to a future outcome for a given
individual. The focus of this review is asthma.
The early origins of respiratory morbidity are
now well described and this is thanks to more
than 50 years of hard work. Initially, respiratory
questions were included among many other
non-respiratory outcomes in large cohorts [1, 2].
Almost 30 years ago, the first cohorts specifi-
cally designed to observe the onset of respira-
tory symptoms were established and some
included physiological measurements in early
infancy [3–5]. A review of 18 European asthma
birth cohort studies which were mostly
recruited during the 1990s concluded that,
despite studies evolving independently, there
were consistent methodologies being applied
across centres such that it was valid to
combined results from these cohorts [6]; this
observation suggests that a standard frame-
work for an asthma cohort study has been
established following the pioneering studies
and adopted by the international research
community. At present, there are approximately
one hundred cohort studies around the world
which are wholly or partly designed to relate
early events to later respiratory morbidity.
Figure 1 places some cohort studies on a world
map. Given the large number of studies and
long follow up of the pioneering cohorts, it is
timely to ask the question: what knowledge has
arisen from asthma cohort studies? What has
previously been concluded is that respiratory
symptoms often start in infancy, exposures
during the first year of life appear to be
important to later asthma outcome and that
there are different patterns of wheeze within a
population [7]. The aims are to 1) explore the
strengths and limitations of cohort studies;
2) discuss what the early exposures may be and
what magnitude of effect they have; 3) identify
factors predictive of asthma outcomes which
have arisen from cohort studies; and 4) sum-
marise results of intervention studies.
Strengths and limitations of cohort
studies
Given that there are so many different cohorts
it is inevitable that there is a wide spectrum
of study design (table 1). Variability in study
design reflects lessons learnt from previous
studies, advances in methods of assessment
and also ethical considerations. The perfect
study would follow up several thousand
individuals from conception to grave and,
during that time, assess all genetic variations
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Figure 1
A map of the world showing the location of many cohort studies (including intervention studies). ALSPAC: Avon
Longitudinal Study of Parents and Children; BAMSE: Children, Allergy, Milieu, Stockholm, Epidemiological
survey; CAPPS: Canadian Asthma Primary Prevention Study; CAPS: Childhood Asthma Prevention Study;
COPSAC: Copenhagen Prospective Study on Asthma in Childhood; KOALA: Child, Parent and Health; Lifestyle
and Genetic Constitution; MAAS: Manchester Asthma and Allergy Study; MAS: German Multicentre Asthma
Study; NZACS: New Zealand Asthma and Allergy Cohort Study; PIAMA: Prevention and Incidence of Mite
Allergy; PIAF: Perth Infant Asthma Follow-up; PREVASC: Prevention of Asthma in Children; PROBIT:
Promotion of Breastfeeding Intervention Trial; SAGE: Study of Asthma Genes and the Environment; SIDRIA:
Italian Studies of Respiratory Disorders in Childhood and the Environment.
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and environmental exposures and relate
these to robust indices of asthma. Life is
not perfect and strengths and weaknesses of
cohort studies are displayed in table 2. The
practical challenges of participant recruitment
and retention and limitation of finances often
mean that most studies are only able to
focus on one exposure/outcome; unfortunately
asthma is a complex disease in which more
than one gene or environmental exposure are
implicated in causation. One limitation to
cohort studies is that results may take many
years to emerge and may not be relevant to
current practice; for example, is it fair to
extrapolate to children in 2012 the results
from participants in the 1958 cohort who
were assessed as children? People who come
forward to participate in respiratory studies
are not always typical of the general population
[8], so results may not necessarily be gener-
alisable even with low rates of drop out.
However, drop out of participants is inevitable
and introduces bias into the remaining study
population (children of smoking and less
affluent parents are more likely to drop out)
and also reduces a study’s power to detect the
presence of an association and, even more so,
the absence of an association. Further limita-
tions are that once a study is underway it is
very hard to retrospectively include additional
exposures and that the associations described
do not necessarily equate to causation. Finally,
the flaw in every asthma study is that there is
no gold standard test or definition for asthma,
Table 1 Differences between the designs of asthma cohort studies. In one study [11] the
majority of study participants were from an unselected population but additionally, an
intervention given to high risk infants was nested within the study design
Category Examples
Age at first data Pre conception cohorts [4], Birth cohorts [1], Childhood cohorts [12]
Inclusion criteria Unselected cohorts [5, 11, 13–16], inclusion of ‘‘high risk infants’’ (e.g. at
least one parent with asthma) [11, 17], inclusion of only patients with
asthma [12]
Respiratory specific? Respiratory and non-respiratory outcomes measured [1, 2], Respiratory/
allergy specific [3, 4]
Exposure Allergen exposure [11], Ambient air quality [18], Breast feeding [19],
Maternal diet [20], Maternal illness during pregnancy [21], Smoking [22]
Table 2. Strengths and weaknesses of asthma cohort studies
Strengths Limitations
Prospective data collection (no recall bias) Can be difficult to change study protocol, e.g.
retrospectively add data, change outcome
Hypothesis driven Still does not prove causation
Essential for intervention studies Recruitment of representative population
Longitudinal analysis can reduce sample size Drop out
Analysis can minimise effect of drop out Often only considers one exposure
Able to consider different exposures at
different times
Cost
Follow up for .10 years often necessary
Lack of gold standard outcome
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and different asthma definitions can invalidate
direct comparison between studies. Given the
lack of a gold standard phenotype for asthma
and heterogeneity in genetic and environmental
characteristics across the world’s population, it
is perhaps not surprising that different studies
yield apparently inconsistent results; one exam-
ple of this is the relationship between breast
feeding and asthma which is positive in some
studies but negative in others [9]. One alter-
native to the typical cohort is to use routinely
acquired data and undertake ‘‘real world’’ whole
population studies; while this is not without
another series of limitations it has been advo-
cated [10] and already used in Scandinavian
countries.
What are the risk factors for asthma?
Can we predict who will get asthma?
Asthma is a classical complex disease in which
a series of genetic and environmental factors
interact, often at critical stages of develop-
ment. As for all complex diseases (e.g. cancer,
ischaemic heart disease), the risk for develop-
ing asthma can be described for the population
but not for the individual. A child at a high risk
for developing asthma may never develop
symptoms and, conversely, a child with no
apparent risk factors may develop troublesome
symptoms. It is not possible to predict who will
and will not develop asthma; instead, what can
be done instead is describe the relative risk
(table 3). The truly novel insight which cohort
studies have provided is the ability to identify
when these factors become important. Many
factors appear to be acting early in life, some
even before birth, but the presence of adult-
onset asthma is evidence that symptoms can
appear at any time during life. To add a further
dimension to the model, there are almost
certainly interactions between factors, e.g.
family history of atopy and breast feeding
[19], atopy and early viral infection [23], and
parental atopy and smoking [24].
What is the evidence that factors are
acting early?
Cohort studies for which physiological mea-
surements were made in asymptomatic infants
or young children who were then followed up
have demonstrated that the hallmarks of
childhood asthma are present before the onset
of symptoms; these features include atopy
[31], reduced lung function [4], bronchial
hyper-reactivity [13] and airway eosinophilia
[32]. Further evidence that early influences are
Table 3 Results from systematic reviews relating relative risk for asthma to factors. This list is not intended to be
exhaustive but serves to illustrate that each factor has a relatively modest association in isolation. What is unknown is
whether relative risks are additive or multiplicative when more than one factor is present for an individual
Risk factor for developing childhood asthma Relative risk [95% CI] Comment
Either parent smoke [25] 1.37 [1.15–1.64]
Maternal asthma [26] 3.04 [2.59–3.56]
Paternal asthma [26] 2.44 [2.14–2.79]
Atopy [27] 1.5 to 4.8
Antenatal paracetamol exposure [28] 1.28 [1.16–41]
Dog exposure [29] 1.14 [1.01–1.29] 1.39 [1.00, 1.95] for any furry pet
Cat exposure [29] 0.72 [0.55–0.93]
Breast feeding [19] 0.70 [0.60–0.81] Lower in atopic families (OR 0.52)
Visible mould [30] 1.49 [1.28–1.72] Mould derived compounds may reduce risk
High maternal vitamin D during pregnancy [20] 0.56 [0.42–0.73] Wheezing outcomes not asthma
High maternal vitamin E during pregnancy [20] 0.68 [0.52–0.88] Wheezing outcomes not asthma
Mediterranean diet during pregnancy [20] 0.22 [0.08–0.58] Wheezing outcomes not asthma
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important to asthma is that reduced fetal size
at ten weeks gestation has been linked to
increased respiratory morbidity in 10-yr-olds
[33]. There are at least two implications for
these findings. First, for many children (and
adults), asthma develops in early life and
second there is a ‘‘pre-asthmatic’’ stage during
which intervention might influence asthma
outcome. Table 3 summarises some of the
early factors associated with asthma and their
possible magnitude of effect.
Which factors are acting early?
Genetic factors
Most asthma cohort studies have collected
DNA from participants and, as a consequence,
many genetic variations associated with asth-
ma have been identified from studies of candi-
date genes and, more recently, genome-wide
association studies. Cohort studies have the
potential to explore the hypothesis that the
relationship between genetic factors and asth-
ma changes over time but there is very little
evidence to support this. What is known is that
a parental history of asthma is associated with
increased risk for childhood asthma [26], and
this suggests that shared genetic and environ-
mental factors are important to asthma causa-
tion. Twin studies have demonstrated how
concordance for asthma in monozygotic twins
is higher than for dizygotic twins (approximately
20 and 5% respectively) [34]. These twin studies
provide evidence that shared genetic factors are
associated with asthma regardless of shared
environmental exposures and, furthermore, are
able to quantify the genetic contribution to
asthma within families as up to 70% [34]. There
is no single asthma gene, rather a small number
of genetic factors, each of which making a
modest contribution to asthma risk. A recent
study has described five genetic factors linked to
asthma in a large European dataset which
included many children [35]. This study is
noteworthy in identifying a genetic variant
(ORMDL3) with childhood onset asthma sug-
gesting that this genetic susceptibility is parti-
cularly apparent early in life [35].
Westernised lifestyle
The International Study of Asthma and Allergy
in Childhood has demonstrated considerable
variability in prevalence of childhood asthma
across the world [36]. Asthma prevalence is
highest in more affluent countries with evi-
dence of increasing prevalence in developing
countries [36]. The higher prevalence of asthma
among children in West Germany (6%) when
compared with East Germany (4%) in the early
1990s gave some insight into the association
between a ‘‘Westernised lifestyle’’ and child-
hood asthma; assuming a similar genetic
pedigree of children in East and West Ger-
many, the different asthma prevalences must be
explained by environment. Children in China
have lower prevalence of asthma symptoms
compared with those in Hong Kong and those
who migrate from China to ‘‘Westernised’’
Hong Kong after the age of 2 years still retain
the apparent protective effect of their early
environment against asthma [37].
Dietary factors
Breast feeding is usually associated with
reduced risk for asthma but this relationship
is not replicated in all studies. Cohort studies
have demonstrated that there is an overall
protective effect of breast feeding on asthma
development [19]. Adults and children with
asthma have, in some studies, been found to
have reduced intake of vitamins A, C and E but
intervention studies in adults have demon-
strated how vitamin supplementation leads to
no meaningful improvement in asthma out-
comes [38]. The dietary hypothesis proposes
that an excess of dietary oxidant or lack of
dietary antioxidants in maternal diet during
pregnancy leads to increased asthma [38]. This
hypothesis has been tested in a number of
populations and the published studies sup-
port the concept of maternal nutrition during
pregnancy being important to early childhood
asthma. This review has considered only
nutrients where consistent findings have
arisen from more than one high-quality cohort
study or where an intervention study has been
completed. Children of mothers with reduced
vitamin D intake are at increased risk for
wheeze [20]. Reduced maternal vitamin E
during pregnancy has also been linked to
increased adverse asthma outcomes in 5-yr
olds including symptoms and lung function
[20]. Increased N6 polyunsaturated fatty acids
(PUFA) and reduced N3 PUFA have been
implicated in atopy causation but there is little
evidence to determine whether these lipids are
important in asthma causation. It seems
improbable that a single nutrient insufficiency
or excess determines asthma risk; factors such
Childhood respiratory cohort studies
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as vitamins C, D, and E may be merely markers
of a ‘‘good’’ diet. What is required is an inter-
vention study to determine whether these
associations are causative.
Early respiratory infection
Cohort studies consistently demonstrate that
bronchiolitis is a risk factor for subsequent
asthma symptoms but this association is
transient in cohorts recruited from the commu-
nity whereas one cohort recruited from infants
admitted with respiratory syncitial virus (RSV)
reported increased asthma at 18 years of age
[39]. A cohort in Australia provided evidence
that early infection with RSV or rhinovirus is
associated with later asthma symptoms but
only in those with co-existent atopy [23].
Exposure to tobacco smoke
Children exposed to secondhand smoke are
at increased risk for many respiratory outcomes
including asthma. Since many children exposed
to SHS were exposed to products of tobacco
smoke in utero it is difficult to determine
whether antenatal or postnatal exposure is
more important to asthma causation. What is
clear is that the relationship between exposure
and asthma is not straightforward. A Finnish
cohort study has demonstrated an interaction
between parental atopy and parental smoking
for asthma [24]. Cohort studies have demon-
strated that genes coding for airway anti-oxidant
defences appear to be important to the presence
of symptoms [40] and physiological measure-
ments [41] in individuals whose mothers
smoked during pregnancy.
Inhaled particles
Further evidence of interactions between envir-
onmental exposures and genetic factors result-
ing in childhood asthma comes from a UK
cohort where environmental exposure to lipopo-
lysaccharide (LPS) was related to risk for wheeze
at age 5 years. When the whole population was
considered, there was no association; but when
subdivided by a gene important to cellular
immune recognition of LPS, those children with
the CC genotype subgroup of the CD14 gene
were at increased risk for wheeze with increasing
exposure (odds ratio approximately 1.4) [42].
Early exposure (mostly by inhalation) to cat and
dog allergen may respectively increase and
decrease later risk for asthma [29].
Atopy
Asthma is primarily a respiratory condition
but is associated with atopy in many cases.
Although not primarily an allergic condition,
asthma is closely related to atopy but this
relationship is inconsistent since many allergic
children are not asthmatic and one quarter of
asthmatic children are non-allergic [27]. Risk
factors for atopy are often different to those for
asthma, e.g. birth order for atopy, exposure to
secondhand smoke for asthma and genetic
factors associated with atopy and typically
not linked with asthma [35]. Atopy has been
estimated to explain approximately 38% of
asthma cases (range 25–63%) [27]. One expla-
nation to this apparently confused relationship
between atopy and asthma is that atopy is
considered as a bivariate outcome but atopy
should be considered a continuous outcome
(for example like forced expiratory volume in
1 s) since type-specific immunoglobulin (Ig)E
comes with a range of values in any population.
Age at onset of atopy is very important, cohort
studies have demonstrated that onset of atopy
before school age is associated with more
severe asthma outcomes [43] and atopy which
develops after age 5 years is probably not
relevant to asthma causation. One paradigm
which explains the relationship between atopy
and asthma is that for an individual with an
underlying airway abnormality (possibly of air-
way epithelial cell function) to develop symp-
toms they either need a markedly abnormal
airway abnormality alone or a modest abnorm-
ality plus modest atopy or perhaps a minor
airway abnormality plus severe atopy.
Who grows out of asthma and can we
predict prognosis? Will my child grow
out of their asthma?
The prospective collection of questionnaire
and physiological data over time allows cohort
studies the luxury of hindsight and some have
developed algorithms that predict outcomes
of early wheeze. Unfortunately, whilst useful
on a whole-population basis, these algorithms
do lack precision. The three most consistent
indices of persisting wheeze are frequent early
wheeze, parental history of asthma and early
onset atopy in the child; these three factors
probably correspond to airway abnormality,
genetic susceptibility and atopy respectively.
Table 4 summarises the relative risk for
different risk factors described in cohort
Childhood respiratory cohort studies
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studies. Due to the challenge in measuring
respiratory physiology in young children, all
but one algorithm combines factors obtained
from the history, some also include allergy
testing [44] and one also includes allergen
exposure [45]. At the time of writing, a single
study has related lung function and nitric oxide
in 4 yr olds to later symptoms and found
limited evidence that these measurements
may be useful [46].
Can we prevent asthma? What can I do
to stop my other children from getting
asthma?
There is no cure for asthma; however, a number
of centres have introduced interventions aimed
at reducing the risk for developing asthma.
These pioneering studies have given important
insight into asthma aetiology during infancy
and highlighted the complexities and pitfalls in
trying to prevent asthma. Single interventions
have proven disappointing whereas multiple
interventions have shown evidence in reducing
asthma symptoms in childhood.
In Manchester, UK, a birth cohort of 251
infants at high risk for allergy was randomised to
an intervention which very effectively removed
house dust mites (HDM) from their environment
for the first year [50]. At age 3 years, the
intervention group were somewhat unexpectedly
at increased risk for HDM sensitisation (OR 2.9;
95% CI 1.0–8.0). The intervention was associated
with a reduction in airway resistance of approxi-
mately 20%. Outcomes beyond 3 years have not
been reported despite the cohort having been
followed up past age 5 years, so it is possible that
the outcomes at 3 years did not persist. What this
study demonstrates is that an apparently simple
intervention can be far from simple. By reducing
HDM exposure, there was an increase in IgE
sensitisation but an unexpected improvement in
lung function, the latter may have been due to
exposure to an adverse exposure, e.g. lipopoly-
saccharide, which was inadvertently reduced by
the intervention. A second intervention study in
the Netherlands introduced the single interven-
tion of HDM reduction and the intervention was
associated with reduced recurrent wheeze during
infancy but not at 2 years of age [11].
A study by Canadian researchers in Belarus
randomised mothers attending 31 maternity
hospitals to an educational intervention aimed
at prolonging extended breast feeding. In total,
Table 4 Summarising relative weight placed on measured variables in children aged 3 years for asthma at 11–13 years
(7–8 years for PIAMA)
Tucson [44] Isle of Wight [47] Leicester#[48] MAS" [45] PIAMA [49]
Early recurrent
wheeze
+++ +++ 1.8 3.9
Parental asthma/
atopy
+++ 2.3 8.3 1.9
Eczema +++ 3.2 2.1
Early IgE
sensitisation
++ 5.7 4.7
Rhinitis ++ 0.4 1.6
Wheeze without
URTI
++ 2.9
Male gender 2.8 1.8
Recurrent chest
infection
2.0 1.8
Ig: immunoglobulin. #: study also validated the Tucson Asthma Predictive Index (API) but concluded that early recurrent wheeze (i.e. at least three
episodes by three years of age) was equivalent in precision to the API; ": study also described interactions between variables, odds ratios (OR)
presented are for those with early recurrent wheeze. +++: greater weight; ++: intermediate weight.
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17,046 infants participated. After 1 year, mothers
who had received the intervention had breastfed
for longer and exclusively breastfed for longer
compared with controls. Infants of mother who
received the intervention were less likely to have
diarrhoeal illnesses and eczema. At 6 years of
age, those in the intervention group were more
likely to be skin-prick positive (OR 2.0; 95% CI
1.1–3.4) but there was no increase or decrease in
asthma symptoms [51].
A birth cohort of 120 infants at high risk for
developing allergy was recruited in the Isle
of Wight, UK. Infants were randomised to a
complex allergen-avoidance intervention aimed
at reducing exposure to HDM and cow’s milk.
At 8 years of age, individuals who received the
intervention were less likely to have current
wheeze (OR 0.3; 95% CI 0.1–1.0) and atopy (OR
0.2; 95% CI 0.1–0.6) [52].
The Childhood Asthma Prevention Study
(CAPS) in Sydney, Australia, sought to reduce
the risk of asthma developing in 616 infants at
higher risk for asthma. The intervention here
was either HDM reduction or dietary supple-
mentation with omega-3 and reduction of
omega-6 fatty acids or both or neither. At
3 years of age, those children who had devel-
oped atopy but who had dietary supplementa-
tion had 10.0% (95% CI 3.7–16.4) reduction in
the prevalence of cough. There was a 7.2% (95%
CI 10.11–14.3) reduction in sensitisation to HDM
in the active allergen avoidance group (p50.05;
number needed to treat: 14) [53]. There are no
published outcomes beyond 3 years despite the
cohort being recruited in the late 1990s.
A randomised–controlled study tested
the effect of a multifaceted intervention pro-
gramme on the primary prevention of asthma
in high-risk infants in Canada. Here, 545 infants
with at least one parent with asthma were
randomised to a complex intervention includ-
ing four components: 1) reduction of house
dust mite exposure; 2) reduction of exposure to
pets; 3) reduced exposure to environmental
tobacco smoke; and 4) avoidance of cow’s milk
protein and delayed weaning. At 7 years of age,
469 children were followed up and the inter-
vention was associated with a reduced risk for
diagnosed asthma of 0.44 (95% CI, 0.25–
0.79), the intervention was not associated with
reduced atopy or BHR so the underlying
mechanism is not clear but was not by delaying
onset of atopy [17].
The outcomes of these studies can be
summarised thus:
Conclusions and future research
Cohort studies continue to give insight into the
timing of early exposures on asthma causation
and their magnitude of effect. Figure 1 demon-
strates that these studies are mostly restricted
to the developed world and similar studies
would be welcomed in Asia and Africa. Given
the changing nature of our environment and
lifestyle, there is justification for more cohort
studies to be recruited and these should
carefully consider their study design to reflect
clinically relevant questions. Whole population
studies in Finland and Sweden validate the use
of routinely acquired data as part of ‘‘real-world’’
studies and these have benefits of yielding rapid
results at low cost. Genetic variations, sex, age
and socioeconomic status are all associated
with altered risk for asthma but are not
modifiable; however, intervention studies can
be designed to modify what can be changed, i.e.
lifestyle, to prevent asthma developing.
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Suggestedanswers
1)Ageatfirstdata;inclusioncriteria;whetherornotitisrespiratoryspecific;exposure
2)Strengths:Prospectivedatacollection(norecallbias);hypothesisdriven;essentialforinterventionstudies;
longitudinalanalysiscanreducesamplesize;analysiscanminimiseeffectofdropout;abletoconsiderdifferent
exposuresatdifferenttime.Weaknesses:canbedifficulttochangestudyprotocol;stilldoesnotprovecausation;
recruitmentofrepresentativepopulation;dropout;oftenonlyconsidersoneexposure;cost;followupfor.10years
oftennecessary;lackofgold-standardoutcome.
3)Increasedrisk:parentsmoke;maternalasthma;paternalasthma;atopy;antenatalparacetamolexposure;dog
exposure.Decreasedrisk:catexposure;breastfeeding;visiblemould;highmaternalvitaminDduringpregnancy;high
maternalvitaminEduringpregnancy;Mediterraneandietduringpregnancy.
4)Earlyrecurrentwheeze;Parentalasthma/atopy;Eczema;EarlyIgEsensitisation,Rhinitis,WheezewithoutURTI,Male
gender,Recurrentchestinfection.
Childhood respiratory cohort studies
Breathe | March 2012 | Volume 8 | No 3204
